Three New Cancer Therapies on Path to EU Approval
At least three of five new medications currently being pushed for approval in the European Union concern cancer therapies focusing on aggressive forms such as small cell lung cancer and bladder cancer. The latest decisions by the European Medicines Agency signal new movement in the European therapeutic arsenal of oncology.